$16.08
0.06% yesterday
Nasdaq, Jun 27, 10:03 pm CET
ISIN
US04280A1007
Symbol
ARWR

Arrowhead Pharmaceuticals, Inc. Stock price

$16.08
+0.71 4.62% 1M
-2.88 15.19% 6M
-2.72 14.47% YTD
-9.61 37.41% 1Y
-17.64 52.31% 3Y
-26.52 62.25% 5Y
+9.18 133.04% 10Y
-13.02 44.74% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
+0.01 0.06%
ISIN
US04280A1007
Symbol
ARWR
Sector
Industry

Key metrics

Basic
Market capitalization
$2.2b
Enterprise Value
$1.4b
Net debt
$-821.4m
Cash
$1.1b
Shares outstanding
138.1m
Valuation (TTM | estimate)
P/E
negative | 380.24
P/S
4.07 | 2.84
EV/Sales
2.57 | 1.79
EV/FCF
145.76
P/B
3.25
Financial Health
Equity Ratio
16.27%
Return on Equity
-323.27%
ROCE
-8.76%
ROIC
-28.37%
Debt/Equity
0.40
Financials (TTM | estimate)
Revenue
$545.2m | $782.1m
EBITDA
$-97.4m | $-132.1m
EBIT
$-118.6m
Net Income
$-144.0m | $5.8m
Free Cash Flow
$9.6m
Growth (TTM | estimate)
Revenue
1,437.97% | 21,930.70%
EBITDA
78.72% | 77.32%
EBIT
74.98%
Net Income
69.42% | 100.97%
Free Cash Flow
102.04%
Margin (TTM | estimate)
Gross
-
EBITDA
-17.87% | -16.89%
EBIT
-21.74%
Net
-26.41% | 0.75%
Free Cash Flow
1.76%
More
EPS
$-1.07
FCF per Share
$0.07
Short interest
11.85%
Employees
609.00
Rev per Employee
$10.00k
Show more

Is Arrowhead Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Arrowhead Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Arrowhead Pharmaceuticals, Inc. forecast:

15x Buy
71%
6x Hold
29%

Analyst Opinions

21 Analysts have issued a Arrowhead Pharmaceuticals, Inc. forecast:

Buy
71%
Hold
29%

Financial data from Arrowhead Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
545 545
1,438% 1,438%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 116 116
8% 8%
21%
- Research and Development Expense 526 526
37% 37%
97%
-97 -97
79% 79%
-18%
- Depreciation and Amortization 21 21
32% 32%
4%
EBIT (Operating Income) EBIT -119 -119
75% 75%
-22%
Net Profit -144 -144
69% 69%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Arrowhead Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Arrowhead Pharmaceuticals, Inc. Stock News

Neutral
Business Wire
5 days ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has completed enrollment in SHASTA-3, SHASTA-4, and MUIR-3, the company's global Phase 3 clinical studies designed to support regulatory submissions for marketing approval of investigational plozasiran in the treatment of severe hypertriglyceridemia. Arrowhead anticipates completi...
Neutral
Business Wire
26 days ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-ALK7, the company's investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for obesity. ARO-ALK7 is designed to intervene in a known pathway that signals the body to store fat ...
Neutral
Business Wire
about one month ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming investor events: Jefferies Global Healthcare Conference – June 4-5, 2025 Type: Fireside Chat Presentation Date/Time: June 4, 2025, 9:20 a.m. EDT 46th Annual Goldman Sachs Global Healthcare Conference – June 9-11, 2025 Type: Fir...
More Arrowhead Pharmaceuticals, Inc. News

Company Profile

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Head office United States
CEO Christopher Anzalone
Employees 609
Founded 1989
Website arrowheadpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today